| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 06/27/2013 | WO2013068563A3 Antibody molecules having specificity for human ox40 |
| 06/27/2013 | WO2013061083A3 Therapeutic agents and uses thereof |
| 06/27/2013 | WO2013048883A3 Anti-erbb3 antibodies and uses thereof |
| 06/27/2013 | WO2013044215A4 Vegf/dll4 binding agents and uses thereof |
| 06/27/2013 | WO2013033609A3 Methods and compositions for the treatment and diagnosis of cancer |
| 06/27/2013 | WO2012085015A9 Anti-il-18 antibodies and their uses |
| 06/27/2013 | WO2011022727A3 Antibodies against the ectodomain of erbb3 and uses thereof |
| 06/27/2013 | US20130167256 Genetic engineering of non-human animals for the production of chimeric antibodies |
| 06/27/2013 | US20130165640 Acceptor framework for cdr grafting |
| 06/27/2013 | US20130165639 Acceptor framework for cdr grafting |
| 06/27/2013 | US20130165638 Light chain-bridged bispecific antibody |
| 06/27/2013 | US20130165637 Use of g-csf dimer in the treatment of neutropenia |
| 06/27/2013 | US20130165629 Bispecific t-cell activator antibody |
| 06/27/2013 | US20130165626 Antifreeze protein |
| 06/27/2013 | US20130165389 Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same |
| 06/27/2013 | US20130164734 Methods and materials for the detection of dengue virus infection |
| 06/27/2013 | US20130164733 Hepatitis-c virus testing |
| 06/27/2013 | US20130164371 Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device |
| 06/27/2013 | US20130164309 Antibodies to the b12-transcobalamin receptor |
| 06/27/2013 | US20130164308 Staphylococcus aureus specific antibodies and uses thereof |
| 06/27/2013 | US20130164307 Use of camelid-derived variable heavy chain variable regions (vhh) targeting human cd18 and icam-1 as a microbicide to prevent hiv-1 transmission |
| 06/27/2013 | US20130164306 Compositions and methods for treating autoimmune and inflammatory disorders |
| 06/27/2013 | US20130164304 Anti-hepcidin antibodies and uses thereof |
| 06/27/2013 | US20130164300 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 06/27/2013 | US20130164299 Llt-1 antibodies with new functional properties |
| 06/27/2013 | US20130164298 P. gingivalis antigenic composition |
| 06/27/2013 | US20130164295 VEGF/DLL4 Binding Agents and Uses Thereof |
| 06/27/2013 | US20130164294 Substance specific to human pd-1 |
| 06/27/2013 | US20130164293 Bispecific binding agents |
| 06/27/2013 | US20130164292 Human Anti-OPGL Neutralizing Antibodies As Selective OPGL Pathway Inhibitors |
| 06/27/2013 | US20130164290 Artificially Produced Polyclonal Immunoglobulin Preparation |
| 06/27/2013 | US20130164289 Human cytomegalovirus vaccine |
| 06/27/2013 | US20130164281 Deimmunized anti c-met humanized antibodies and uses thereof |
| 06/27/2013 | US20130164278 Humanized antibody |
| 06/27/2013 | US20130164256 Immunobinders directed against tnf |
| 06/27/2013 | US20130164250 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof |
| 06/27/2013 | US20130164216 Bladder cancer tumor marker, antibody and use thereof |
| 06/27/2013 | DE112011102411T5 Verfahren zur Behandlung von Aufmerksamkeits-Mangel-Hyperaktivitäts-Störung A method of treating Attention Deficit Hyperactivity Disorder |
| 06/27/2013 | CA2858963A1 Vaccines against hpv |
| 06/27/2013 | CA2858125A1 Method for selectively quantifying a-beta aggregates |
| 06/27/2013 | CA2855894A1 Pseudomonas aeruginosa oprm epitopes for use in diagnostics and therapeutics |
| 06/27/2013 | CA2854249A1 Expression vector element combinations, novel production cell generation methods and their use for the recombinant production of polypeptides |
| 06/27/2013 | CA2854246A1 Full length antibody display system for eukaryotic cells and its use |
| 06/27/2013 | CA2854243A1 Rapid method for cloning and expression of cognate antibody variable region gene segments |
| 06/26/2013 | EP2607379A1 Variants derived from ActRIIB and uses therefor |
| 06/26/2013 | EP2606899A1 High viscosity macromolecluar compositions for treating ocular conditions |
| 06/26/2013 | EP2606071A1 Anti-human igg1 antibody |
| 06/26/2013 | EP2606070A1 Antibodies for epidermal growth factor receptor 3 (her3) |
| 06/26/2013 | EP2606069A1 Humanized anti-interleukin 3 receptor alpha chain antibodies |
| 06/26/2013 | EP2606068A1 Combined use of fc gamma riib (cd32b) and cd20 - specific antibodies |
| 06/26/2013 | EP2606067A2 Anti-ngf antibodies and their use |
| 06/26/2013 | EP2606066A1 Antibodies that bind myostatin, compositions and methods |
| 06/26/2013 | EP2606065A2 Improved anti-serum albumin binding variants |
| 06/26/2013 | EP2606064A2 Methods for the generation of multispecific and multivalent antibodies |
| 06/26/2013 | EP2606063A2 Improved antibodies of the class igg4 |
| 06/26/2013 | EP2605793A1 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody |
| 06/26/2013 | EP2605791A2 Anti-lps enriched immunoglobulin preparation for use in treatment and/or prophylaxis of a pathologic disorder |
| 06/26/2013 | EP2605788A2 Combination therapy with anti-cd74 antibodies provides enhanced toxicity to malignancies, autoimmune disease and other diseases |
| 06/26/2013 | EP1392815B1 Enzymes having alpha amylase activity and methods of use thereof |
| 06/26/2013 | CN1589278B Recombinant allergen with reduced IgE binding but undiminished T-cell antigenicity |
| 06/26/2013 | CN103180342A Antibodies for the treatment of HIV |
| 06/26/2013 | CN103180341A Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin |
| 06/26/2013 | CN103180340A Intracellular immunity |
| 06/26/2013 | CN103180339A Fibronectin based scaffold proteins having improved stability |
| 06/26/2013 | CN103179985A Antibodies that bind csf1r |
| 06/26/2013 | CN103175961A Enzyme linked immunosorbent assay kit for detecting 21 sulfonamides and 11 quinolones and application of enzyme linked immunosorbent assay kit |
| 06/26/2013 | CN103173459A Mouse-anti-human T cell antigen ZCH-2B8a monoclonal antibody variable region gene and use |
| 06/26/2013 | CN103173458A Sequences of variable regions of anti-GFAP (glial fibrillary acidic protein) monoclonal antibody and method for preparing same |
| 06/26/2013 | CN103173457A Sequences of variable regions of anti-CD20 monoclonal antibody and method for preparing same |
| 06/26/2013 | CN103173447A Novel beta-actin and rps21 promoters and uses thereof |
| 06/26/2013 | CN103173420A Hybridoma cell capable of secreting anti-cardiac troponin I monoclonal antibodies and applications thereof |
| 06/26/2013 | CN103173419A Chemokine-4 resisting monoclonal antibody, chemokine-4 resisting hybridoma cell line and applications of monoclonal antibody |
| 06/26/2013 | CN103173418A Mouse anti-human PCNA (Proliferating Cell Nuclear Antigen) monoclonal antibody and hybridoma cell strain secreting same |
| 06/26/2013 | CN103173417A Mouse anti-human CEA (Carcino-Embryonic Antigen) monoclonal antibody and hybridoma cell strain secreting same |
| 06/26/2013 | CN103173416A Mouse anti-human CK19 (Cytokeratin 19) monoclonal antibody and hybridoma cell strain secreting same |
| 06/26/2013 | CN103173415A Mouse anti-human EGFR (Epithelial Growth Factor Receptor) monoclonal antibody and hybridoma cell strain secreting same |
| 06/26/2013 | CN103173414A Mouse anti-human P504S monoclonal antibody and hybridoma cell strain for secreting monoclonal antibody |
| 06/26/2013 | CN103173413A Mouse anti-human beta-catenin monoclonal antibody and hybridoma cell strain for secreting monoclonal antibody |
| 06/26/2013 | CN103173412A Mouse anti-human CD20 monoclonal antibody and hybridoma cell strain for secreting monoclonal antibody |
| 06/26/2013 | CN103172744A Monoclonal antibodies for specifically identifying B-Raf mutant proteins, preparation method and applications thereof |
| 06/26/2013 | CN103172743A Human Antibodies That Bind Cd22 And Uses Thereof |
| 06/26/2013 | CN103172742A Antibodies specific for human CD22 and their therapeutic and diagnostic uses |
| 06/26/2013 | CN103172741A New fully human antibody |
| 06/26/2013 | CN103172740A Preparation method of beta-estradiol analogue antibody and use thereof |
| 06/26/2013 | CN103172739A IL-12/P40 binding proteins |
| 06/26/2013 | CN103172738A IL-12/P40 binding proteins |
| 06/26/2013 | CN103172737A IL-12/P40 binding proteins |
| 06/26/2013 | CN103172736A Humanized monoclonal antibodies to hepatocyte growth factor |
| 06/26/2013 | CN103172735A Anti-system asc amino acid transporter 2 (asct2) antibody |
| 06/26/2013 | CN103172734A Humanized anti-anthrax-toxin protective antigen neutralizing antibody Fab and applications thereof |
| 06/26/2013 | CN103172733A Preparation method of hyperimmune yolk antibody against very virulent infectious bursal disease virus (vvIBDV) |
| 06/26/2013 | CN103172732A Anti-gosling plague egg yolk antibody and preparation method thereof |
| 06/26/2013 | CN103172731A Optimized Fc variants |
| 06/26/2013 | CN103172728A Preparation method and application of diethylstilbestrol cationization complete antigen |
| 06/26/2013 | CN103172705A Hepatitis C virus (HCV) B cell epitope peptide PUHI16 and application thereof |
| 06/26/2013 | CN103172525A Preparation method of ethyl vanillin antigen and antibody, and application of ethyl vanillin antigen and antibody |
| 06/26/2013 | CN103170309A Ractopamine antibody immunoaffinity chromatographic column and application thereof |
| 06/26/2013 | CN103168924A Method for preparing livestock and poultry feed additive (peptide YY egg yolk antibody powder) |
| 06/26/2013 | CN101936983B Method for detecting sulfonamide compound and special quantum dot fluorescent immune kit thereof |
| 06/26/2013 | CN101918433B Peptides specific for hepatocellular carcinoma cells and applications thereof |